HER2positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients (NCT07560475) | Tianjin Medical University Cancer Institute and Hospital | 2026-06-10 |
Track HER2positive automatically
Every clearance here is in the API, with alerts when new ones post.